EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieOpen Access · CC BY 4.0

Exploring determinants in deciding the optimal antimicrobial dose in patients undergoing CRRT: a mixed-methods study

Tuğba Yanık Yalçın iD, Aysel Pehlivanlı iD, Fatma İrem Yeşiler iD, Helin Şahintürk iD, Özlem Azap iD, Hande Arslan iD, Bilgen Başgut iD, Pınar Zeyneloğlu iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00238-25 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Tuğba Yanık Yalçın und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Baskent University, Ankara, Turkey. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Continuous Renal Replacement Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial dosing in patients undergoing continuous renal replacement therapy (CRRT) is a clinical challenge. The study aimed to investigate the factors that influence appropriate antimicrobial doses in CRRT and to address gaps in current knowledge and practice. The mixed-method design involved two phases. For the quantitative phase, infectious disease, intensive care, and clinical pharmacy professionals completed a questionnaire assessing demographics and practice details, as well as their knowledge, attitudes, and practices on antibiotic dosing in CRRT. In the qualitative phase, online focus groups were conducted using a question schedule based on the Theoretical Domains Framework to explore challenges and expectations. A structured questionnaire was completed by 160 participants, most of whom were infectious disease specialists (61.3%) with over 10 years of experience (38.8%). Despite a high knowledge level of antimicrobial dosing during CRRT, the sieving coefficient was unclear at 74.4%. Although 96.3% reported adjusting doses, 78.8% lacked institutional guidelines, and 68.1% did not monitor drug levels. CRRT experience positively influenced knowledge and attitude scores, and different dosing practices were reported for meropenem, piperacillin-tazobactam, and vancomycin. Qualitative findings highlighted the need for standard guidelines and CRRT-specific training. Multidisciplinary collaboration and real-time monitoring of therapeutic drugs were emphasized. This study identifies key gaps in knowledge and practice regarding antimicrobial dosing in CRRT. Addressing these gaps requires targeted training programs, real-time drug monitoring, and the development of evidence-based dosing guidelines to enhance patient safety and antimicrobial efficacy. Future research should evaluate the impact of these interventions on clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsContinuous Renal Replacement TherapyHumansMaleFemaleSurveys and QuestionnairesMeropenemMiddle AgedPiperacillin, Tazobactam Drug CombinationAdultFocus GroupsHealth Knowledge, Attitudes, PracticeVancomycin

Stichwörter der Autor:innen

drug dosage calculationspharmaceutical arithmeticqualitative evaluationquantitative evaluationrenal replacement therapies

Substanzen

Anti-Bacterial AgentsMeropenemPiperacillin, Tazobactam Drug CombinationVancomycin

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Baskent University, Ankara, Turkey.
  • Department of Pharmacology, Faculty of Pharmacy, Baskent University, Ankara, Turkey.
  • Clinical Pharmacy and Drug Information Center, Baskent University Ankara Hospital, Ankara, Turkey.
  • Department of Anesthesiology and Critical Care Unit, Faculty of Medicine, Baskent University, Ankara, Turkey.

ORCID-Profile: Tuğba Yanık Yalçın, Aysel Pehlivanlı, Fatma İrem Yeşiler, Helin Şahintürk, Özlem Azap, Hande Arslan, Bilgen Başgut, Pınar Zeyneloğlu

Zitieren

APA

Yanık Yalçın, T., Pehlivanlı, A., Yeşiler, F. İ., Şahintürk, H., Azap, Ö., Arslan, H., Başgut, B., & Zeyneloğlu, P. (2025). Exploring determinants in deciding the optimal antimicrobial dose in patients undergoing CRRT: a mixed-methods study. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00238-25

Vancouver

Yanık Yalçın T, Pehlivanlı A, Yeşiler Fİ, Şahintürk H, Azap Ö, Arslan H, et al. Exploring determinants in deciding the optimal antimicrobial dose in patients undergoing CRRT: a mixed-methods study. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00238-25

BibTeX
@article{YankYaln2025,
  author = {Yanık Yalçın, Tuğba and Pehlivanlı, Aysel and Yeşiler, Fatma İrem and Şahintürk, Helin and Azap, Özlem and Arslan, Hande and Başgut, Bilgen and Zeyneloğlu, Pınar},
  title = {Exploring determinants in deciding the optimal antimicrobial dose in patients undergoing CRRT: a mixed-methods study},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00238-25}
}
Kostenlos starten →